TSS
NKGN

Two Sigma Securities’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Two Sigma Securities’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,495
Closed -$14.7K – 2375
2024
Q4 		$14.7K Sell
22,495
-1,980
-8% -$807 ﹤0.01% 1371
2024
Q3 		$9.25K Buy
+24,475
New +$21.7K ﹤0.01% 2601

Other funds holding NKGN

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Two Sigma Securities's NKGN Position: Q1 2025 in Review

Two Sigma Securities sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2025, closing a stake of 22,495 shares — an estimated $14.7K sold.

Two Sigma Securities first reported a position in NKGN in Q3 2024 and held it in 2 quarters. The position peaked at $14.7K in Q4 2024. 3 funds tracked by Wall St. Rank hold NKGN as of Q1 2025.

  • Two Sigma Securities reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 22,495 NKGen Biotech, Inc. Common Stock shares in Q1 2025, an estimated $14.7K.
  • Two Sigma Securities first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
  • Two Sigma Securities's NKGen Biotech, Inc. Common Stock position peaked at $14.7K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.